Pediatric CancerRFAOPNCT03803735
Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
An observational study of Pediatric Cancer, run by French Africa Pediatric Oncology Group at 14 sites in 12 countries.
Trial summary
The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population. Read more about this study
- Who is it for?
- Ages 1 day to 18 years
- Conditions the study is for
- Pediatric Cancer
- How many people
- 10,000 participants
- Where
- 14 sitesin 12 countries
- Study dates
- 1 Jan 2016to Dec 2030
- How long will I take part?
- 12 Months
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 1 day to 18 years
- All sexes
- Child, Adult
Study population: All childre with any pediatric cancer types, coming into any one of the participating units in a 12 month period.
Who may be able to join
- Any child presenting at any one of the participating units for treatment
- Any child with any type of cancer
- Any child or adolescent less than 18 years of age.
Who cannot join
- No cancer found
- Age greater than 18 years -
Trial locations and contacts
14 sites in 12 countries. Contact the study team or a site near you to ask about taking part.
14 sites in 12 countries
Burkina Faso2 sites, 2 recruiting
- Recruiting
Hopital Yalgado Ouedraogo
Ouagadougou, 03 BP 7022
BOUDA CHANTAL, DR
- Recruiting
Centre Hospitalier Universitaire Pédiatrique Charles De Gaulle
Ouagadougou
Sonia Ms Kaboret, Dr
kawajo200046@gmail.com
Democratic Republic of the Congo2 sites, 2 recruiting
- Recruiting
Cliniques Universitaires de Kinshasa
Kinshasa, Kinshasa City, BP 12 KIN XI
BUDIONGO Aléine, DR
- Recruiting
Cliniques Universitaires de Lubumbashi (CUL)
Lubumbashi, BP 1825
Robert LUKAMBA, DR, 00(243) 814024633, robertlukamba@yahoo.fr
Cameroon1 site, 1 recruiting
- Recruiting
Centre Mère et Enfant CME-FCB (Fondation Chantal Biya)
Yaoundé
Angèle PONDY, PROFESSEU, 237) 677 030 892, pondyangele@yahoo.fr
Côte d’Ivoire1 site, 1 recruiting
- Recruiting
CHU de Treichville à ABIDJAN
Abidjan, Abidjan Autonomous District
Line Guei COUITCHERE, MD
France1 site, 1 recruiting
- Recruiting
GFAOP
Villejuif, PARIS, 00094
BRENDA MALLON, MSC, 0033661519474, brenda.mallon@gustaveroussy.fr
CATHERINE PATTE, DR, 0033142116560, catherine.patte@gustaveroussy.fr
Gabon1 site, 1 recruiting
- Recruiting
l'Institut de Cancérologie de Libreville
Libreville
Betty NDAKISSA, DR
Madagascar1 site, 1 recruiting
- Recruiting
HJRA, Hôpital universitaire Joseph Ravoahangy Andrianavalona
Antananarivo, Ampefiloha, BP 4150
Mbola RAKOTOMAHEFA, DR, (261) 33 05 055 66, mahefambola@yahoo.fr
Mali1 site, 1 recruiting
- Recruiting
CHU Gabriel Touré (HGT)
Bamako
Boubacar TOGO, PROFESSEUR, +223 66 74 29 04, boubacar.togo@gfaop.org
Mauritania1 site, 1 recruiting
- Recruiting
Centre National d'Oncologie (CNO)
Nouakchott
Ekhtel Benina ZEIN, DR, 222 45 24 22 32
Niger1 site, 1 recruiting
- Recruiting
CNLC, Centre National de Lutte contre le Cancer
Niamey
Aichatou MAHAMADOU, DR
Senegal1 site, 1 recruiting
- Recruiting
Hôpital Aristide Le Dantec, Avenue Pasteur, BP 3001
Dakar, Dakar
DIAGNE AKONDE Fatou-Binetou, Dr, 00(221)77 637 40 63, fabakonde@gmail.com
Togo1 site, 1 recruiting
- Recruiting
CHU Sylvanus Olympio
Lomé, BP 57
Koffi Mawuse Jules GUEDENON, DR
About this study
Official title: French African Pediatric Oncology Registry
The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to plan and provide correct pediatric oncology treatment and care for this population.
Collecting the data will give much needed information on numbers, stage, treatment and outcome. The register will give data for local and national health authorities in planning pediatric cancer programs.
Read the detailed description
This register is a registration of all children entering hospital based pediatric oncology units, working in selected hospitals in French speaking Africa. The data collected includes: demographic and socioeconomic status as well as clinical status and outcome.
The register also collects information on vital status, treatment abandonment and loss to follow-up.
Data, collected locally is entered on line using the Research Electronic Data Capture (REDCap) program. Data are stored under the responsibility of the IT department at Gustave ROUSSY in Paris- Villejuif.
- Conditions
- Pediatric Cancer
- Medical subject headings
- Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of children with a suspicion of any type of cancer in a given unit
Number of children with details of :
- the type of cancer
- the stage of the identified cancer coming into a given unit
Measured: in any 12 month period
VITAL STATUS:
Dead or alive
- The number of children living
- the number of children dead
Measured: in any 12 month period
Illness status
- The number of children relapsed,
- The number of children whos illness has progressed.
Measured: in any 12 month period
Treatment Status
- The number of children who had treatment administered,
- The number of children who abandoned treatment
Measured: in any 12 month period
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2019
- Study start1 Jan 2016
- Primary completionDec 2030 (estimated)
- Study completionDec 2030 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pediatric CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 10,000 participants (estimated)
- Target duration
- 12 Months
Sponsor and investigators
- Lead sponsor
- French Africa Pediatric Oncology Group
- Sponsor type
- University, hospital or other
- Collaborators
- Gustave Roussy, Cancer Campus, Grand Paris
- Responsible party
- Sponsor
- Investigators
- Brenda Mallon, MSc, Study director, French Africa Pediatric Oncology Group
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03803735
- Sponsor's protocol ID
- GFAOP
- Acronym
- RFAOP
- Status last verified
- Sep 2025
- First submitted
- 8 Nov 2018
- Last updated
- 3 Oct 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Units have acess to their own data and can use it for reporting.